Healthy volunteers to test new heart failure drug formulation
NCT ID NCT07476157
First seen Mar 26, 2026 · Last updated May 25, 2026 · Updated 7 times
Summary
This study tests two versions of a drug (AD-118 and AD-1181) in 70 healthy adults to see how they are processed in the body and if they are safe. Participants take a single dose of each version on separate days after fasting. The goal is to gather information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H PLUS YANGJI HOSPITAL, Seoul
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.